Company: CERO
Filing Date: 2025-01-03
Form Type: 424B3
Source: 0001213900-25-000475
Chunk: 4

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-01-03
Form: 424B3
Chunk 4
---
for cash proceeds of approximately $700 thousand.

<div align='center'>1

SIGNATURES</div>

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.

| Date: December 31, 2024 | CERO THERAPEUTICS HOLDINGS, INC. |                         |
|:------------------------|:---------------------------------|:------------------------|
|                         | By:                              | /s/ Chris Ehrlich       |
|                         | Name:                            | Chris Ehrlich           |
|                         | Title:                           | Chief Executive Officer |

<div align='center'>2</div>